In vitro Comparison of Three Salbutamol-Containing Multidose Dry Powder Inhalers
Objective: To compare the in vitro drug delivery characteristics of three salbutamol-containing multidose dry powder inhalers, Buventol Easyhaler®, Inspiryl Turbuhaler® and Ventoline Diskus®.
Materials and Methods: Dose accuracy and consistency, fine particle dose (FPD)/fine particle fraction (FPF), and mass median aerodynamic diameter (MMAD) [measured by Multi-Stage Liquid Impinger] were determined for each inhaler at variable airflow rates (30 and 60 L/min) and at ‘equivalent’ flow rates (corresponding to a 4kPa pressure drop).
Results: Dose accuracy and consistency (expressed as percentage of label claim) of Easyhaler® (mean 95%, SD <4.5% at 30 to 60 L/min) compared favourably with that of Turbuhaler® (mean 88%, SD 19% at 60 L/min) and Diskus® (mean 93%, SD 8% at 90 L/min). The FPF at an ‘equivalent’ flow rate was 21% for Easyhaler®, 24% for Turbuhaler® and 20% for Diskus®. The FPF of Turbuhaler® was strongly influenced by flow rate (12 to 24% at 30 to 60 L/min), whereas the FPF of Easyhaler® (16 to 23% at 30 to 60 L/min) and Diskus® (15 to 21% at 30 to 90 L/min) was less variable. MMAD values for Easyhaler® and Turbuhaler® were stable at flow rates of 30 to 60 L/min, whereas the particle size distribution for Diskus® was more dependent on flow rate. Easyhaler® had a considerably lower MMAD than Turbuhaler® at flow rates of 30 to 60 L/min.
Conclusions: This study demonstrated favourable dose delivery and consistency with Buventol Easyhaler® compared with Inspiryl Turbuhaler® and Ventoline Diskus®. Delivered dose and FPF showed less flow dependency with Easyhaler® and Diskus® than with Turbuhaler®.
- 6.Hickey AJ, Concessio NM, Van Oort MM, et al. Factors influencing the dispersion of dry powder as aerosols. Pharm Technol 1994; 8: 58–64Google Scholar
- 7.Moren F. Towards satisfactory in vitro testing requirements for single and multi-dose powder inhalers. J Pharm Sci 1992; 3: 123–9Google Scholar
- 9.European Pharmacopoeia. 3rd ed. Supplement. Strasbourg: Council of Europe, 1999Google Scholar
- 12.Brindley A, Sumby BS, Smith IJ, et al. Design, manufacture and dose consistency of the Serevent Diskus inhaler. Pharm Technol Eur 1995; 7: 14–22Google Scholar
- 14.Palander A, Halme A, Kananen M, et al. In vitro performance of inhalers: salbutamol-containing dry powder products. J Aerosol Med 1999; 12: 113Google Scholar
- 18.Malton A, Sumby BS, Smith IJ. A comparison of in vitro drug delivery from two multidose powder inhalation devices. Eur J Clin Res 1995; 7: 177–93Google Scholar
- 19.Prime D, Slater AL, Haywood PA, et al. Assessing dose delivery from the Flixotide Diskus inhaler —a multidose powder inhaler. Pharm Technol Eur 1996; 8: 23–8Google Scholar